Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan.
FEMS Microbiol Lett. 2010 Mar;304(2):148-56. doi: 10.1111/j.1574-6968.2010.01899.x. Epub 2010 Jan 11.
Mycinamicin, a 16-membered macrolide antibiotic produced by Micromonospora griseorubida, comprises a macrolactone and two deoxysugars: desosamine and mycinose. Mycinose is synthesized through two modification steps: the methylation of 6-deoxyallose in mycinamicin VI and of javose in mycinamicin III. To confirm the role of mycE and mycF genes in mycinamicin biosynthesis in M. griseorubida, disruption mutants of mycE and mycF were constructed by disruption plasmids containing attB in the disruption cassette FRT-neo-oriT-FRT-attB for the integration of phiC31-derivative vector plasmids; the disruption mutants were complemented through the integration of pSET152 derivatives containing intact mycE or mycF into the artificially inserted attB site. These disruption mutants did not produce mycinamicin II, but mainly accumulated mycinamicins VI and III, indicating that MycE and MycF methylated the C2''-OH group of 6-deoxyallose in mycinamicin VI and the C3''-OH group of C2''-methylated 6-deoxyallose in mycinamicin III, respectively. The complemented strains of mycE and mycF recovered the mycinamicin II productivity.
麦迪霉素,一种由灰色小单孢菌产生的 16 元大环内酯抗生素,由大环内酯和两个去氧糖:去甲氨基己糖和麦迪糖组成。麦迪糖通过两个修饰步骤合成:麦迪霉素 VI 中 6-脱氧阿洛糖和麦迪霉素 III 中爪哇糖的甲基化。为了确认 mycE 和 mycF 基因在灰色小单孢菌中麦迪霉素生物合成中的作用,通过在带有 attB 的断裂盒 FRT-neo-oriT-FRT-attB 中的断裂质粒构建 mycE 和 mycF 的断裂突变体,用于 phiC31 衍生物载体质粒的整合;通过将含有完整 mycE 或 mycF 的 pSET152 衍生物整合到人工插入的 attB 位点,对断裂突变体进行了互补。这些断裂突变体不产生麦迪霉素 II,但主要积累麦迪霉素 VI 和 III,表明 MycE 和 MycF 分别甲基化了麦迪霉素 VI 中 6-脱氧阿洛糖的 C2''-OH 基团和麦迪霉素 III 中 C2''-甲基化 6-脱氧阿洛糖的 C3''-OH 基团。mycE 和 mycF 的互补菌株恢复了麦迪霉素 II 的生产力。